Skip to main content

Month: April 2024

Exela Technologies Holdings, Inc. Reports Full Year 2023 Results

2023 revenue of $1,064.1 million, down 1.2% year-over-year Gross margin of 21.7% in 2023 vs 18.5% in 2022 Operating profit of $8.1 million, up $236.8 million due to increased gross margin, lower SG&A and no impairments in 2023 versus 2022 Net loss of $124.4 million ($125.1 attributable to Exela Technologies Inc), an improvement of $291.4 million year-over-year Certain of the Company’s subsidiaries issued approximately $764.8 million of aggregate principal amount of new notes in exchange for $956.0 million of aggregate principal amount of existing 2026 notes in 2023IRVING, Texas, April 04, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for the full year ended December 31, 2023. “2023...

Continue reading

Gorilla Reports Record 2023 Financial Results

— 2023 revenues up 189% YoY compared to 2022, highlighting continued success globally —— High value product and services business model reflected in 2023 gross margin of 69% —— Total net income of $19.9 million, compared to ($87.5 million), a 123% increase YoY —— Adj. EBITDA of $29.0 million, compared to ($6.0) million, a 587% increase YoY — LONDON, April 04, 2024 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today reported financial results for the fiscal year ending December 31, 2023. 2023 Financial HighlightsRevenue Growth: Full-year 2023 revenues catapulted to $64.7 million, marking a substantial 189% increase year-over-year....

Continue reading

Reliance Global Group’s Revenue Grows by 17% and 40% in 2023 Compared to 2022 and 2021, respectively

Acquisition letter of intent previously announced progresses to final stages of definitive agreement discussions Company to Host Conference Call Today at 1:00 PM Eastern Time LAKEWOOD, N.J., April 04, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”) today provided a business update and reported financial results for the year ended December 31, 2023. “We are pleased to report 17% and 40% year-over-year increases in revenue for 2023 compared to 2022 and 2021, respectively,” commented Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group. “Of the 17% revenue increase, 67% relates to organic growth, and 33% was acquisition related.” “Our net loss was substantially driven by non-core operating and non-cash expense charges, such as, net estimate &...

Continue reading

Radius Recycling Reports Second Quarter Fiscal 2024 Financial Results

Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Increased Cost Reduction Target by $40 Million Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2024 (GLOBE NEWSWIRE) — Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the second quarter of fiscal 2024 ended February 29, 2024. The Company reported a loss per share from continuing operations of $(1.19) and a net loss of $(34) million. Adjusted EBITDA was $3 million and adjusted loss per share from continuing operations was $(1.04).   Market conditions during the second quarter remained challenging, as tight supply flows for recycled metals and unusually wet winter weather impacted sales volumes and metals spreads for both recycled metals and finished steel. Scrap generation remained constrained due to persistently low levels of manufacturing...

Continue reading

O-I Glass Appoints Gordon Hardie as Chief Executive Officer

Gordon Brings Over 35 Years of Global Leadership Experience Advancing Strategy and Innovation Company Nominates Two New Independent Directors and Announces Retirement of Board Chair PERRYSBURG, Ohio, April 04, 2024 (GLOBE NEWSWIRE) —  O-I Glass, Inc. (NYSE: O-I) (the “Company” or “O-I”) today announced that its Board of Directors (the “Board”) has appointed Gordon J. Hardie, current O-I Board member, as the Company’s next Chief Executive Officer, effective the later of May 15, 2024 or the date Gordon is issued his work-authorized U.S. visa. Gordon will also continue as a member of O-I’s Board, where he has served since 2015. He succeeds Andres Lopez, who previously announced his intention to retire. Gordon is a seasoned executive who brings over 35 years of leadership and operational expertise, including overseeing transformations...

Continue reading

Landsbankinn hf.: S&P raises Landsbankinn’s credit rating to BBB+

International rating agency S&P Global Ratings today announced that it has upgraded the credit rating of Landsbankinn. The credit rating is raised by one notch, to BBB+ with stable outlook. As per S&P’s announcement, the upgrade reflects their expectations that Landsbankinn will maintain its leading domestic franchise and sound business operations. S&P considers the economic outlook in Iceland favourable and expects that GDP growth here will outpace other Nordics. Lilja Björk Einarsdóttir, CEO of Landsbankinn: “I am very pleased and this is excellent news for us all. Improved credit rating reflects extensive and successful long-standing work by the Bank and the strong standing of the Icelandic economy. We have endeavoured to be a dynamic competitor and are a leading Icelandic bank, as mentioned by S&P. Successful...

Continue reading

ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes

Atherosclerosis (AS) and its sequelae are the most common cause of death in diabetic patients and one of the reasons why diabetes has entered the top 10 causes of death worldwide. The published data show that inhibiting the NLRP3 inflammasome pathway significantly reduces atherosclerotic lesions and improves hyperglycemic-induced plaque instability. ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome ASC and ASC specks from multiple types of inflammasomes, including NLRP3, to block initiation and perpetuation of damaging inflammation that promotes atherosclerosis and its progression, among numerous other inflammatory diseases.WESTON, Fla., April 04, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class...

Continue reading

Tim Lamb Group Brokers Sale of Metro Toyota in Brook Park, Ohio to Victory Automotive Group

This purchase makes Victory Automotive Group’s 11th Toyota DealershipMetro Toyota ClosingThe Sale of Metro Toyota occurred on Monday, March 18, 2024. Pictured Left to Right Steve Corle (Director at Tim Lamb Group), Eric Cappo (Chief Financial Officer at Victory Automotive Group), and Ken Schneider (General Manager at Metro Toyota) photo credit Tim Lamb GroupMetro Toyota DealershipMetro Toyota Dealership credit Metro ToyotaColumbus, OH, April 04, 2024 (GLOBE NEWSWIRE) — Steve Corle, Director of the Plains Region for the Tim Lamb Group, headquartered in Columbus, the largest auto dealership sales, and acquisitions firm in North America, has brokered the sale of Metro Toyota in Ohio to Michigan based Victory Automotive Group.  Metro Toyota was owned previously by Jerry Schneider, sons Ken Scheider and Dan...

Continue reading

The Simply Good Foods Company Reports Fiscal Second Quarter 2024 Financial Results and Updates Full Fiscal Year 2024 Net Sales and Adjusted EBITDA Outlook

DENVER, April 04, 2024 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen weeks ended February 24, 2024. Second Quarter Summary:(1)Net sales of $312.2 million versus $296.6 million Net income of $33.1 million versus $25.6 million Earnings per diluted share (“EPS”) of $0.33 versus $0.25 Adjusted Diluted EPS(2) of $0.40 versus $0.32 Adjusted EBITDA(4) $57.8 million versus $50.9 millionFull fiscal year 2024 Net Sales and Adjusted EBITDA(3) outlook(4):Net sales expected to increase around the mid-point of the Company’s long-term algorithm of 4-6%, including the benefit of a fifty-third week. The Company previously expected Net Sales to increase...

Continue reading

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates. Business Updates Comprehensive Transformation Plan At the Emerging Growth Investor Conference on March 7, 2024, our new management team announced a comprehensive transformation plan to deliver a step change in the financial performance of our existing business. Our transformation plan for the existing business has several key components that we believe are rapidly achievable, in most cases by mid-2025:We are reducing complexity and cost by consolidating our main manufacturing operations into a considerably...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.